{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:09:36Z","timestamp":1789477776412,"version":"build-2803163510"},"reference-count":74,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.14797\/mdcvj.1851","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:54:23Z","timestamp":1789476863000},"page":"40-50","source":"Crossref","is-referenced-by-count":0,"title":["Genetic and Conventional Risk Stratification Are Complementary for Primary Prevention of CAD"],"prefix":"10.14797","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9234-5449","authenticated-orcid":false,"given":"Robert","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacKenna","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"5","key":"key20260915125851_B1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJMra1201534","article-title":"Measuring the Global Burden of Disease","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"key20260915125851_B2","unstructured":"World Heart Federation [Internet]. Geneva, Switzerland: World heart Federation; c2026. Deaths from cardiovascular disease surged 60% globally over the last 30 years: Report; 2023 May 20 [cited 2026 Jul 25]. Available from: https:\/\/world-heart-federation.org\/news\/deaths-from-cardiovascular-disease-surged-60-globally-over-the-last-30-years-report\/"},{"issue":"2","key":"key20260915125851_B3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2008.01.004","article-title":"Balancing cholesterol synthesis and absorption in the gastrointestinal tract","volume":"2","year":"2008","journal-title":"J Clin Lipidol"},{"issue":"7","key":"key20260915125851_B4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI0216452","article-title":"Consequences of cellular cholesterol accumulation: basic concepts and physiological implications","volume":"110","year":"2002","journal-title":"J Clin Invest"},{"issue":"4","key":"key20260915125851_B5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"key20260915125851_B6","first-page":"256","article-title":"Free cholesterol-induced cytotoxicity a possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions","volume":"7","year":"1997","journal-title":"Trends Cardiovasc Med"},{"issue":"11","key":"key20260915125851_B7","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1074\/jbc.270.11.5772","article-title":"Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol","volume":"270","year":"1995","journal-title":"J Biol Chem"},{"issue":"2","key":"key20260915125851_B8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"32","key":"key20260915125851_B9","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","year":"2017","journal-title":"Eur Heart J"},{"issue":"24","key":"key20260915125851_B10","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","year":"2020","journal-title":"Eur Heart J"},{"issue":"5","key":"key20260915125851_B11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","article-title":"Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease","volume":"131","year":"2015","journal-title":"Circulation"},{"issue":"22","key":"key20260915125851_B12","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.jacc.2020.04.027","article-title":"Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease","volume":"75","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"key20260915125851_B13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2020.06.030","article-title":"Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults","volume":"76","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"key20260915125851_B14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","year":"2003","journal-title":"Eur Heart J"},{"issue":"6","key":"key20260915125851_B15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study","volume":"117","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"key20260915125851_B16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","year":"2007","journal-title":"JAMA"},{"issue":"25","key":"key20260915125851_B17","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.jacc.2016.10.039","article-title":"Genetics: Implications for Prevention and Management of Coronary Artery Disease","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20260915125851_B18","first-page":"1241","article-title":"A decade of genome-wide association studies for coronary artery disease: the challenges ahead","volume":"114","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"6","key":"key20260915125851_B19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1056\/NEJMra2405153","article-title":"The Inherited Basis of Coronary Artery Disease","volume":"394","year":"2026","journal-title":"N Engl J Med"},{"issue":"1","key":"key20260915125851_B20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41467-025-68129-x","article-title":"Preventing premature deaths through polygenic risk scores","volume":"17","year":"2026","journal-title":"Nat Commun"},{"issue":"10","key":"key20260915125851_B21","first-page":"972","article-title":"Coronary artery atherosclerosis revisited in Korean war combat casualties","volume":"111","year":"1987","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"key20260915125851_B22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0735-1097(93)90050-B","article-title":"Manifestations of coronary atherosclerosis in young trauma victims--an autopsy study","volume":"22","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"key20260915125851_B23","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"key20260915125851_B24","article-title":"Heart Disease and Stroke Statistics\u20142015 Update: A Report From the American Heart Association","volume":"131","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"key20260915125851_B25","article-title":"Quantification of Coronary Atherosclerosis in the Pre-Peri Menopausal Female Based on Cardiac CCTA","volume":"4","year":"2024","journal-title":"Int J Clin Cardiol Cardiovasc Interv"},{"issue":"8","key":"key20260915125851_B26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9149(97)89309-5","article-title":"Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia","volume":"77","year":"1996","journal-title":"Am J Cardiol"},{"issue":"13","key":"key20260915125851_B27","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2020.08.004","article-title":"\u201cCholesterol-Years\u201d for ASCVD Risk Prediction and Treatment","volume":"76","year":"2020","journal-title":"Am Coll Cardiol"},{"issue":"25","key":"key20260915125851_B28","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"key20260915125851_B29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of Lipids on Cardiovascular Health","volume":"72","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"key20260915125851_B30","first-page":"e67","article-title":"Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association","volume":"137","year":"2018","journal-title":"Circulation"},{"issue":"9493","key":"key20260915125851_B31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","year":"2005","journal-title":"Lancet"},{"issue":"10059","key":"key20260915125851_B32","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","year":"2016","journal-title":"Lancet"},{"issue":"9753","key":"key20260915125851_B33","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"key20260915125851_B34","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis","volume":"316","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"key20260915125851_B35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00045415-199405000-00003","article-title":"Gene-Environment Interactions and Gene Therapy in Atherosclerosis","volume":"2","year":"1994","journal-title":"Cardiol Rev"},{"issue":"5","key":"key20260915125851_B36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2174\/1389202921999200630145241","article-title":"A Journey through Genetic Architecture and Predisposition of Coronary Artery Disease","volume":"21","year":"2020","journal-title":"Curr Genomics"},{"issue":"7164","key":"key20260915125851_B37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature06258","article-title":"A second generation human haplotype map of over 3.1 million SNPs","volume":"449","author":"International HapMap Consortium","year":"2007","journal-title":"Nature"},{"issue":"5830","key":"key20260915125851_B38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1142447","article-title":"A common allele on chromosome 9 associated with coronary heart disease","volume":"316","year":"2007","journal-title":"Science"},{"issue":"5830","key":"key20260915125851_B39","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1142842","article-title":"A common variant on chromosome 9p21 affects the risk of myocardial infarction","volume":"316","year":"2007","journal-title":"Science"},{"issue":"7145","key":"key20260915125851_B40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"The Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nature"},{"issue":"5","key":"key20260915125851_B41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa072366","article-title":"Genomewide association analysis of coronary artery disease","volume":"357","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"key20260915125851_B42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/CIRCGENETICS.109.899443","article-title":"Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-analysis Involving More Than 22 000 Cases and 60 000 Controls","volume":"3","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"issue":"12","key":"key20260915125851_B43","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","article-title":"Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants","volume":"54","year":"2022","journal-title":"Nat Genet"},{"issue":"6","key":"key20260915125851_B44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrg.2016.160","article-title":"Genetics of coronary artery disease: discovery, biology and clinical translation","volume":"18","year":"2017","journal-title":"Nat Rev Genet"},{"issue":"1","key":"key20260915125851_B45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12265-021-10144-6","article-title":"A Less than Provocative Approach for the Primary Prevention of CAD","volume":"15","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"issue":"9984","key":"key20260915125851_B46","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","year":"2015","journal-title":"Lancet"},{"issue":"22","key":"key20260915125851_B47","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting","volume":"135","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"key20260915125851_B48","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/CIRCULATIONAHA.119.043805","article-title":"Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial","volume":"141","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"key20260915125851_B49","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.119.044434","article-title":"Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial","volume":"141","year":"2020","journal-title":"Circulation"},{"issue":"16","key":"key20260915125851_B50","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention","volume":"72","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20260915125851_B51","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","year":"2018","journal-title":"Nat Genet"},{"issue":"24","key":"key20260915125851_B52","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"issue":"24","key":"key20260915125851_B53","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1161\/CIRCULATIONAHA.117.032432","article-title":"Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study","volume":"137","year":"2018","journal-title":"Circulation"},{"issue":"20","key":"key20260915125851_B54","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/eurheartj\/ehae048","article-title":"Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease","volume":"45","year":"2024","journal-title":"Eur Heart J"},{"issue":"34","key":"key20260915125851_B55","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/eurheartj\/ehae342","article-title":"Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting","volume":"45","year":"2024","journal-title":"Eur Heart J"},{"issue":"2","key":"key20260915125851_B56","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","year":"2003","journal-title":"Nat Genet"},{"issue":"2","key":"key20260915125851_B57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","year":"2005","journal-title":"Nat Genet"},{"issue":"5","key":"key20260915125851_B58","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacbts.2018.08.001","article-title":"Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval","volume":"3","year":"2018","journal-title":"JACC Basic Transl Sci"},{"issue":"6788","key":"key20260915125851_B59","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.aee2317","article-title":"Genetic information in insurance: Guiding questions for state regulation","volume":"391","year":"2026","journal-title":"Science"},{"key":"key20260915125851_B60","unstructured":"U.S. Equal Employment Opportunity Commission [Internet]. Washington, DC: U.S. Equal Employment Opportunity Commission; c2026. Genetic Information Nondiscrimination Act of 2008; 2008 [cited 2026 Apr 16]. Available from: https:\/\/www.eeoc.gov\/statutes\/genetic-information-nondiscrimination-act-2008"},{"key":"key20260915125851_B61","unstructured":"National Human Genome Research Institute [Internet]. Bethesda, MD: National Human Genome Research Institute; c2026. Genetic Discrimination; 2028 [cited 2026 Apr 16]. Available from: https:\/\/www.genome.gov\/about-genomics\/policy-issues\/Genetic-Discrimination"},{"issue":"1","key":"key20260915125851_B62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1556264615624078","article-title":"Participants and Study Decliners\u2019 Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing","volume":"11","year":"2016","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"5","key":"key20260915125851_B63","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s10897-018-0243-7","article-title":"Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium","volume":"27","year":"2018","journal-title":"J Genet Couns"},{"key":"key20260915125851_B64","unstructured":"Prince AER. Insurance Risk Classification in an Era of Genomics: Is a Rational Discrimination Policy Rational? Neb Law Rev. 2017;96(3):624-687. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6934377\/"},{"key":"key20260915125851_B65","unstructured":"vLex [Internet]. Miami, FL: vLex; c206. Acara v. Banks; 2006 Nov [cited 2026 Apr 16]. Available from: https:\/\/case-law.vlex.com\/vid\/acara-v-banks-no-889713490"},{"issue":"7","key":"key20260915125851_B66","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d Research Program","volume":"381","author":"The All of Us Research Program Investigators","year":"2019","journal-title":"N Engl J Med"},{"issue":"6706","key":"key20260915125851_B67","article-title":"Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program","volume":"385","year":"2024","journal-title":"Science"},{"issue":"6","key":"key20260915125851_B68","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jacc.2020.06.024","article-title":"Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians","volume":"76","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"key20260915125851_B69","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study","volume":"28","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"key20260915125851_B70","author":"MedRxiv [Internet]","year":"2024"},{"issue":"11","key":"key20260915125851_B71","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2019.3502","article-title":"Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial","volume":"4","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"4","key":"key20260915125851_B72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/eurheartj\/ehab532","article-title":"How to live to 100 before developing clinical coronary artery disease: a suggestion","volume":"43","year":"2022","journal-title":"Eur Heart J"},{"key":"key20260915125851_B73","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"key20260915125851_B74","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/eurheartj\/ehae649","article-title":"Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology","volume":"46","year":"2025","journal-title":"Eur Heart J"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:59:06Z","timestamp":1789477146000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1851\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["10.14797\/mdcvj.1851"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1851","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}